Curis Lifesciences Limited IPO
Curis Lifesciences Limited was a SME IPO in the Pharmaceuticals sector, offered at ₹120–₹128 per share to raise ₹28 crore. It listed on 14 Nov 2025 at ₹146 and closed its first day at ₹141, a listing gain of +10.2% versus the ₹128 issue price. It now trades around ₹180 (+40.6% versus the issue price).
Frequently asked questions
- What were the Curis Lifesciences Limited IPO listing gains?
- Curis Lifesciences Limited listed on 14 Nov 2025 at ₹146, closing its first day at ₹141 — a listing gain of +10.2% versus the ₹128 issue price.
- What was the price band and lot size of the Curis Lifesciences Limited IPO?
- The price band was ₹120–₹128 per share.
- Who were the registrar and lead manager for the Curis Lifesciences Limited IPO?
- MUFG Intime India Private Limited was the registrar, and Finaax Capital Advisors was the book-running lead manager.